Explore

Innovations

Published

Healthcare & Pharmaceuticals

Inhibitors Against SARS-CoV-2

Researchers at UArizona have developed inhibitors for two cysteine proteases that are encoded by SARS-CoV-2: the main protease (Mpro) and the papain-like protease (PLpro).

By The University of Arizona

Do you have an innovative technology, product or service?

Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.

Add your Innovation

View all